CFF Supporting Phase 1/2 Trial of Phage Therapy for P. aeruginosa Infections
BiomX has been given up to $5 million to support a clinical trial of BX004, a phage therapy to fight Pseudomonas aeruginosa
-
CFF Supporting Phase 1/2 Trial of Phage Therapy for P. aeruginosa Infections
More boards from Vern Gambold
Notice label will go here